Distinct and overlapping mechanisms of resistance to azacytidine and guadecitabine in acute myeloid leukemia

Emily Gruber^{1

2}, Rheana L Franich¹, Jake Shortt^{1

3

4}, Ricky W Johnstone^{1

2}, Lev M Kats^{5

6}

Affiliations

¹ The Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.
² The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, 3052, VIC, Australia.
³ Monash Haematology, Monash Health, Clayton, 3168, VIC, Australia.
⁴ School of Clinical Sciences at Monash Health, Monash University, Clayton, 3168, VIC, Australia.
⁵ The Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia. lev.kats@petermac.org.
⁶ The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, 3052, VIC, Australia. lev.kats@petermac.org.

Emily Gruber et al. Leukemia. 2020 Dec.

. 2020 Dec;34(12):3388-3392.

doi: 10.1038/s41375-020-0973-z. Epub 2020 Jul 13.

Emily Gruber^{1

2}, Rheana L Franich¹, Jake Shortt^{1

3

4}, Ricky W Johnstone^{1

2}, Lev M Kats^{5

6}

¹ The Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.
² The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, 3052, VIC, Australia.
³ Monash Haematology, Monash Health, Clayton, 3168, VIC, Australia.
⁴ School of Clinical Sciences at Monash Health, Monash University, Clayton, 3168, VIC, Australia.
⁵ The Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia. lev.kats@petermac.org.
⁶ The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, 3052, VIC, Australia. lev.kats@petermac.org.

No abstract available

References

1. Quintás-Cardama A, Santos FPS, Garcia-Manero G. Therapy with azanucleosides for myelodysplastic syndromes. Oncogene. 2010;7:433–44.
1. Tsai H-C, Li H, Van Neste L, Cai Y, Robert C, Rassool FV, et al. Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer Cell. 2012;21:430–46. - DOI
1. Chiappinelli KB, Strissel PL, Desrichard A, Li H, Henke C, Akman B, et al. Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses. Cell. 2015;162:974–86. - DOI
1. Roulois D, Loo Yau H, Singhania R, Wang Y, Danesh A, Shen SY, et al. DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts. Cell. 2015;162:961–73. - DOI
1. Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A, et al. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol. 2009;10:223–32. - DOI